| 释义 |
- Education and career
- Awards
- Controversy
- Selected publications
- See also
- References
{{Use dmy dates|date=June 2018}}{{Use Indian English|date=June 2018}}{{Infobox scientist
|name = Gopal Kundu
|image =
|image_size = 200px
|birth_date = {{Birth date and age|1959|11|2|df=yes}}
|birth_place = Bataspur, West Bengal
|death_date =
|death_place =
|residence = Pune
|citizenship =
|nationality = Indian
|ethnicity =
|field = Cancer
|work_institutions = National Centre for Cell Science
|alma_mater =
|doctoral_advisor =
|doctoral_students =
|known_for = Therapeutics; Biomarker (cell); Angiogenesis; Nanomedicine;
|author_abbrev_bot =
|author_abbrev_zoo =
|influences =
|influenced =
|prizes = N-BIOS Prize, Shanti Swarup Bhatnagar Prize for Science and Technology
|footnotes =
|signature =
}}Gopal Chandra Kundu (born 1959) is an renowned Indian cell and cancer biologist and a Senior Scientist (Scientist-G) at National Centre for Cell Science.[1] He is known for his contributions towards the understanding the mechanism of cancer progression in breast, melanoma and other cancers and development of novel therapeutic targets and target-based therapy in cancers.[2]An elected fellow of the Indian Academy of Sciences[3] and the National Academy of Sciences, India,[4] he received the National Bioscience Award for Career Development of the Department of Biotechnology in 2003.[5] The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2004, for his contributions to biological sciences.[6] Education and career Kundu obtained his Ph.D. from Bose Institute, Kolkata, India (1989) in protein biochemistry and did his post-doctoral research work at the Cleveland Clinic Foundation, University of Colorado, University of Wyoming, and the National Institutes of Health from 1989 to 1998. He has performed work in the area of cardiovascular biology, inflammation and immunomodulation during that period. In 1998, he joined as Scientist-D at the National Centre for Cell Science (NCCS), Pune.[7] At present, he is working as Scientist-G at NCCS. His area of research at NCCS is tumor biology, regulation of gene expression, cell signaling, angiogenesis, cancer therapeutics, biomarker studies for cancer detection, and nanomedicine.[8][9] He is Fellow of The National Academy of Sciences, India, and Indian Academy of Sciences. He is member of American Society for Biochemistry and Molecular Biology and New York Academy of Sciences.{{citation needed|date=June 2018}} He has published 70 papers in peer reviewed international journals.{{citation needed|date=June 2018}} He serves as Editorial Board Member of Current Molecular Medicine, Molecular Medicine Reports, The Open Cancer Journal and American Journal of Cancer Research.{{citation needed|date=June 2018}} AwardsIn 2004 Kundu was awarded a Shanti Swarup Bhatnagar Prize for Science and Technology,[10][11] following the receipt of an earlier National Bioscience Award for Career Development in 2003.[11] International Journal of Oncology, Oncology Reports and International Journal of Molecular Medicine Award for an outstanding achievement in Oncology, Greece; International Young Investigator Award, USA. 7th National Grassroots Innovation Award-2013, Rashtrapati Bhavan, New Delhi. ControversyA controversy erupted in the NCCS in 2006 when an anonymous mail alleged that Kundu and others might have misrepresented data in a paper published in the Journal of Biological Chemistry. The allegation was that they had rehashed the same set of data which they had published earlier.[12] An internal committee of the NCCS advised the authors to take back their paper, however an independent committee led by G. Padmanabhan, a former director of Indian Institute of Science, Bangalore, concluded that there was no manipulation in the data.[13] This led to some heated debate between Indian Scientists with several viewpoints being presented.[14][15] On 23 February 2007, the Journal of Biological Chemistry withdrew the paper amid allegations of data manipulation, although the authors maintained that the two papers used different set of data though similar experiments. One JBC paper was retracted by JBC [16] because they found the data to be unreliable.[17] In November 2010, after an internal investigation by its ethics committee, the Indian Academy of Sciences banned Gopal Kundu from participating in its activities for three years.[18] Selected publications- {{cite journal | last1 = Philip | first1 = S | last2 = Bulbule | first2 = A | last3 = Kundu | first3 = GC | year = 2001 | title = Osteopontin stimulates tumor growth and activation of pro-matrix metalloproteinase-2 through NF-kappa B mediated induction of membrane type 1-matrix metalloproteinase in murine melanoma cells | url = | journal = J. Biol. Chem. | volume = 276 | issue = 48| pages = 44926–44935 | doi=10.1074/jbc.m103334200| pmid = 11564733 }}
- {{cite journal | last1 = Mahabeleshwar | first1 = GH | last2 = Kundu | first2 = GC | year = 2003 | title = Syk, a protein tyrosine kinase, suppresses the cell motility and NF-kappa B mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells | url = | journal = J. Biol. Chem. | volume = 278 | issue = 8| pages = 6209–6221 | doi=10.1074/jbc.m208905200 | pmid=12477728}}
- {{cite journal | last1 = Philip | first1 = S | last2 = Kundu | first2 = GC | year = 2003 | title = Osteopontin induces NF-kappa B mediated promatrix metalloproteinase-2 activation through IKK/IκBα signaling pathways and curcumin (diferulolylmethane) down regulates these pathways | url = | journal = J. Biol. Chem. | volume = 278 | issue = 16| pages = 14487–14497 | doi=10.1074/jbc.m207309200| pmid = 12473670 }}
- {{cite journal | last1 = Das | first1 = R | last2 = Mahabeleshwar | first2 = GH | last3 = Kundu | first3 = GC | year = 2003 | title = Osteopontin stimulates cell motility and NF-kB mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells | url = | journal = J. Biol. Chem. | volume = 278 | issue = 31| pages = 28593–28606 | doi=10.1074/jbc.m303445200| pmid = 12771144 }}
- {{cite journal | last1 = Mahabeleshwar | first1 = GH | last2 = Kundu | first2 = GC | year = 2003 | title = Tyrosine kinase, p56lck regulates cell motility and NF-kB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkBa following hypoxia/reoxygenation | url = | journal = J. Biol. Chem. | volume = 278 | issue = 52| pages = 52598–52612 | doi=10.1074/jbc.m308941200| pmid = 14534291 }}
- {{cite journal | last1 = Mahabeleshwar | first1 = GH | last2 = Das | first2 = R | last3 = Kundu | first3 = GC | year = 2004 | title = Tyrosine kinase, p56lck-induced cell motility and urokinase type plasminogen activator secretion involves activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways | url = | journal = J. Biol. Chem. | volume = 279 | issue = 11| pages = 9733–9742 | doi=10.1074/jbc.m311400200}}
- {{cite journal | last1 = Das | first1 = R | last2 = Mahabeleshwar | first2 = GH | last3 = Kundu | first3 = GC | year = 2004 | title = Osteopontin induces AP-1-mediated secretion of urokinase type plasminogen activator through c-Src dependent EGF receptor transactivation in breast cancer cells | url = | journal = J. Biol. Chem. | volume = 279 | issue = 12| pages = 11051–11064 | doi=10.1074/jbc.m310256200 | pmid=14704150}}
- {{cite journal | last1 = Rangaswami | first1 = H | last2 = Bulbule | first2 = A | last3 = Kundu | first3 = GC | year = 2004 | title = Nuclear factor inducing kinase plays crucial role in osteopontin induced MAPK/IKK dependent nuclear factor kB-mediated promatrix metalloproteinase-9 activation | url = | journal = J. Biol. Chem. | volume = 279 | issue = 37| pages = 38921–38935 | doi=10.1074/jbc.m404674200| pmid = 15247285 }}
- {{cite journal | last1 = Rangaswami | first1 = H | last2 = Bulbule | first2 = A | last3 = Kundu | first3 = GC | year = 2006 | title = Osteopontin: role in cell signaling and cancer progression | url = | journal = Trends Cell Biol. | volume = 16 | issue = 2| pages = 79–87 | doi=10.1016/j.tcb.2005.12.005 | pmid=16406521}}
- {{cite journal | last1 = Chakraborty | first1 = G | last2 = Rangaswami | first2 = R | last3 = Jain | first3 = S | last4 = Kundu | first4 = GC | year = 2006 | title = Hypoxia regulates crosstalk between Syk and Lck leading to breast cancer progression and angiogenesis | url = | journal = J. Biol. Chem. | volume = 281 | issue = 16| pages = 11322–11331 | doi=10.1074/jbc.m512546200| pmid = 16474166 }}
- {{cite journal | last1 = Jain | first1 = S | last2 = Chakraborty | first2 = G | last3 = Kundu | first3 = GC | year = 2006 | title = The Crucial Role of cyclooxygenase-2 in osteopontin-induced PKCα/c-Src/IKKα/β dependent prostate tumor progression and angiogenesis | url = | journal = Cancer Research | volume = 66 | issue = 13| pages = 6638–6648 | doi=10.1158/0008-5472.can-06-0661| pmid = 16818637 }}
- {{cite journal | last1 = Chakraborty | first1 = G | last2 = Jain | first2 = S | last3 = Kundu | first3 = GC | year = 2008 | title = Osteopontin promotes VEGF dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms | url = | journal = Cancer Research | volume = 68 | issue = 1| pages = 152–161 | doi=10.1158/0008-5472.can-07-2126 | pmid=18172307}}
- {{cite journal | last1 = Jain | first1 = S | last2 = Chakraborty | first2 = G | last3 = Raja | first3 = R | last4 = Kale | first4 = S | last5 = Kundu | first5 = GC | year = 2008 | title = Prostaglandin E2 regulates tumor angiogenesis in prostate cancer | url = | journal = Cancer Research | volume = 68 | issue = 19| pages = 7750–7759 | doi=10.1158/0008-5472.can-07-6689 | pmid=18829529}}
- {{cite journal | last1 = Behera | first1 = R | last2 = Kumar | first2 = V | last3 = Lohite | first3 = K | last4 = Karnik | first4 = S | last5 = Kundu | first5 = GC | year = 2010 | title = Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells | url = | journal = Carcinogenesis | volume = 31 | issue = 2| pages = 192–200 | doi=10.1093/carcin/bgp289 | pmid=19926637}}
- {{cite journal | last1 = Ahmed | first1 = M | last2 = Kundu | first2 = GC | year = 2010 | title = Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappa B dependent AP-1-mediated ICAM-1 expression in breast cancer cells | url = | journal = Molecular Cancer | volume = 9 | issue = 1| page = 101 | doi=10.1186/1476-4598-9-101| pmid = 20459645 | pmc = 2881115 }}
- {{cite journal | last1 = Sharma | first1 = P | last2 = Kumar | first2 = S | last3 = Kundu | first3 = GC | year = 2010 | title = Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells | url = | journal = Molecular Cancer | volume = 9 | issue = 1| page = 178 | doi=10.1186/1476-4598-9-178| pmid = 20609221 }}
- {{cite journal | last1 = Kumar | first1 = V | last2 = Behera | first2 = R | last3 = Lohite | first3 = K | last4 = Karnik | first4 = S | last5 = Kundu | first5 = GC | year = 2010 | title = p38 Kinase is Crucial for Osteopontin-induced Furin Expression that Supports Cervical Cancer Progression | url = | journal = Cancer Research | volume = 70 | issue = 24| pages = 10381–10391 | doi=10.1158/0008-5472.can-10-1470 | pmid=20980434}}
- {{cite journal | last1 = Panda | first1 = JJ | last2 = Kaul | first2 = A | last3 = Kumar | first3 = S | last4 = Alam | first4 = S | last5 = Mishra | first5 = AK | last6 = Kundu | first6 = GC | last7 = Chauhan | first7 = VS | year = 2013 | title = Modified dipeptide-based nanoparticles: vehicles for targeted tumor drug delivery | url = | journal = Nanomedicine (Lond.) | volume = 8| issue = 12| pages = 1927–42 | doi = 10.2217/nnm.12.201 | pmid = 23398497 }}
- {{cite journal | last1 = Raja | first1 = R | last2 = Kale | first2 = S | last3 = Thorat | first3 = D | last4 = Gowrishankar | first4 = S | last5 = Lohite | first5 = K | last6 = Mane | first6 = A | last7 = Karnik | first7 = S | last8 = Kundu | first8 = GC | year = 2013 | title = Hypoxia driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF dependent angiogenesis | url = | journal = Oncogene | volume = 33| issue = 16| pages = 2053–2064| doi = 10.1038/onc.2013.171 | pmid = 23728336 }}
- {{cite journal | last1 = Kale | first1 = S | last2 = Raja | first2 = R | last3 = Thorat | first3 = D | last4 = Gowrishankar | first4 = S | last5 = Patil | first5 = TV | last6 = Kundu | first6 = GC | year = 2013 | title = Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin | url = | journal = Oncogene | volume = 33| issue = 18| pages = 2295–2306| doi = 10.1038/onc.2013.184 }}
- {{cite journal | last1 = Mishra | first1 = R | last2 = Thorat | first2 = D | last3 = Soundararajan | first3 = G | last4 = Pradhan | first4 = SJ | last5 = Chakraborty | first5 = G | last6 = Lohite | first6 = K | last7 = Karnik | first7 = S | last8 = Kundu | first8 = GC | date = Mar 2015 | title = Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis | url = | journal = Oncogene | volume = 34 | issue = 12| pages = 1584–95 | doi = 10.1038/onc.2014.79 | pmid = 24727891 }}
- {{cite journal | last1 = Ghosh | first1 = S | last2 = Adhikary | first2 = A | last3 = Chakraborty | first3 = S | last4 = Bhattacharjee | first4 = P | last5 = Mazumder | first5 = M | last6 = Putatunda | first6 = S | last7 = Gorain | first7 = M | last8 = Chakraborty | first8 = A | last9 = Kundu | first9 = GC | last10 = Das | first10 = T | last11 = Sen | first11 = PC | date = Feb 2015 | title = Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimine | journal = J Biol Chem | volume = 290 | issue = 7| pages = 3936–49 | doi = 10.1074/jbc.M114.594028 | pmid = 25527500 | pmc=4326803}}
- {{cite journal | last1 = Mishra | first1 = R | last2 = Kumar | first2 = D | last3 = Tomar | first3 = D | last4 = Chakraborty | first4 = G | last5 = Kumar | first5 = S | last6 = Kundu | first6 = GC | date = Mar 2015 | title = The potential of class 3 semaphorins as both targets and therapeutics in cancer | url = | journal = Expert Opin Ther Targets | volume = 19 | issue = 3| pages = 427–42 | doi = 10.1517/14728222.2014.986095 | pmid = 25434284 }}
- {{cite journal | last1 = Nanjappa | first1 = V | last2 = Renuse | first2 = S | last3 = Sathe | first3 = GJ | last4 = Raja | first4 = R | last5 = Syed | first5 = N | last6 = Radhakrishnan | first6 = A | last7 = Subbannayya | first7 = T | last8 = Patil | first8 = A | last9 = Marimuthu | first9 = A | last10 = Sahasrabuddhe | first10 = NA | last11 = Guerrero-Preston | first11 = R | last12 = Somani | first12 = BL | last13 = Nair | first13 = B | last14 = Kundu | first14 = GC | last15 = Prasad | first15 = TK | last16 = Califano | first16 = JA | last17 = Gowda | first17 = H | last18 = Sidransky | first18 = D | last19 = Pandey | first19 = A | last20 = Chatterjee | first20 = A | date = Oct 2015 | title = Chronic exposure to chewing tobacco selects for overexpression of stearoyl-CoA desaturase in normal oral keratinocytes | journal = Cancer Biol Ther. | volume = 16 | issue = 11| pages = 1593–603 | doi = 10.1080/15384047.2015.1078022 | pmid = 26391970 | pmc=4846103}}
- {{cite journal | last1 = Ghosh | first1 = S | last2 = More | first2 = P | last3 = Derle | first3 = A | last4 = Kitture | first4 = R | last5 = Kale | first5 = T | last6 = Gorain | first6 = M | last7 = Avasthi | first7 = A | last8 = Markad | first8 = P | last9 = Kundu | first9 = GC | last10 = Kale | first10 = S | last11 = Dhavale | first11 = DD | last12 = Bellare | first12 = J | last13 = Chopade | first13 = BA | date = Dec 2015 | title = Diosgenin Functionalized Iron Oxide Nanoparticles as Novel Nanomaterial Against Breast Cancer | url = | journal = J Nanosci Nanotechnol | volume = 15 | issue = 12| pages = 9464–72 | doi=10.1166/jnn.2015.11704| pmid = 26682367 }}
- {{cite journal | last1 = Rustagi | first1 = Y | last2 = Jaiswal | first2 = HK | last3 = Rawal | first3 = K | last4 = Kundu | first4 = GC | last5 = Rani | first5 = V | date = Oct 2015 | title = Comparative Characterization of Cardiac Development Specific microRNAs: Fetal Regulators for Future | url = | journal = PLOS ONE | volume = 10 | issue = 10| page = e0139359 | doi = 10.1371/journal.pone.0139359 | pmid = 26465880 | pmc = 4605649 }}
- {{cite journal | last1 = Mukherjee | first1 = Shravanti | last2 = Manna | first2 = Argha | last3 = Bhattacharjee | first3 = Pushpak | last4 = Mazumdar | first4 = Minakshi | last5 = Saha | first5 = Shilpi | last6 = Chakraborty | first6 = Samik | last7 = Guha | first7 = Deblina | last8 = Adhikary | first8 = Arghya | last9 = Jana | first9 = Debarshi | last10 = Gorain | first10 = Mahadeo | last11 = Mukherjee | first11 = Sanhita | last12 = Kundu | first12 = G. C. | last13 = Sarkar | first13 = Diptendra | last14 = Das | first14 = Tanya | date = Feb 2016 | title = Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4+ migrating cancer stem cells | url = | journal = Oncogene | volume = 35| issue = 37| pages = 4937–4948| doi = 10.1038/onc.2016.26 | pmid = 26923331 }}
- {{cite journal | last1 = Kumar | first1 = Dhiraj | last2 = Kumar | first2 = Santosh | last3 = Gorain | first3 = Mahadeo | last4 = Tomar | first4 = Deepti | last5 = Patil | first5 = Harshal S. | last6 = Radharani | first6 = NNV | last7 = Kumar | first7 = TVS | last8 = Patil | first8 = Tushar V. | last9 = Thulasiram | first9 = H. V. | last10 = Kundu | first10 = G. C. | year = 2016 | title = Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis | url = | journal = Journal of Investigative Dermatology | volume = 136 | issue = 12| pages = 2462–2474 | doi = 10.1016/j.jid.2016.07.024 | pmid = 27476721 }}
- {{cite journal |doi=10.1158/1535-7163.MCT-16-0391 |pmid=27765853 |title=Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma |journal=Molecular Cancer Therapeutics |volume=15 |issue=12 |pages=2966–2976 |year=2016 |last1=Dai |first1=Xiaoyun |last2=Ahn |first2=Kwang Seok |last3=Wang |first3=Ling Zhi |last4=Kim |first4=Chulwon |last5=Deivasigamni |first5=Amudha |last6=Arfuso |first6=Frank |last7=Um |first7=Jae-Young |last8=Kumar |first8=Alan Prem |last9=Chang |first9=Young-Chae |last10=Kumar |first10=Dhiraj |last11=Kundu |first11=Gopal C |last12=Magae |first12=Junji |last13=Goh |first13=Boon Cher |last14=Hui |first14=Kam Man |last15=Sethi |first15=Gautam }}
- {{cite journal |doi=10.1186/s12943-016-0578-3 |pmid=28137308 |pmc=5282877 |title=Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma |journal=Molecular Cancer |volume=16 |issue=1 |pages=7 |year=2017 |last1=Kumar |first1=Dhiraj |last2=Gorain |first2=Mahadeo |last3=Kundu |first3=Gautam |last4=Kundu |first4=Gopal C }}
- {{cite journal |doi=10.1038/cddis.2017.123 |pmid=28358369 |pmc=5386529 |title=MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2 |journal=Cell Death & Disease |volume=8 |issue=3 |pages=e2706 |year=2017 |last1=Ghosh |first1=Alip |last2=Dasgupta |first2=Debanjali |last3=Ghosh |first3=Amit |last4=Roychoudhury |first4=Shrabasti |last5=Kumar |first5=Dhiraj |last6=Gorain |first6=Mahadeo |last7=Butti |first7=Ramesh |last8=Datta |first8=Simanti |last9=Agarwal |first9=Shaleen |last10=Gupta |first10=Subash |last11=Krishna Dhali |first11=Gopal |last12=Chowdhury |first12=Abhijit |last13=Schmittgen |first13=Thomas D |last14=Kundu |first14=Gopal C |last15=Banerjee |first15=Soma }}
- {{cite journal |doi=10.2147/IJN.S139212 |pmid=28979122 |title=Green synthesis of selenium nanoparticles using Acinetobacter sp. SW30: Optimization, characterization and its anticancer activity in breast cancer cells |journal=International Journal of Nanomedicine |pages=6841–6855 |year=2017 |last1=Wadhwani |first1=Sweety |last2=Gorain |first2=Mahadeo |last3=Banerjee |first3=Pinaki |last4=Shedbalkar |first4=Utkarsha |last5=Singh |first5=Richa |last6=Kundu |first6=Gopal |last7=Chopade |first7=Balu A |volume=12}}
- {{cite journal |doi=10.15252/embr.201643347 |pmid=28887320 |title=P53 gain‐of‐function mutations increase Cdc7‐dependent replication initiation |journal=EMBO Reports |volume=18 |issue=11 |pages=2030–2050 |year=2017 |last1=Datta |first1=Arindam |last2=Ghatak |first2=Dishari |last3=Das |first3=Sumit |last4=Banerjee |first4=Taraswi |last5=Paul |first5=Anindita |last6=Butti |first6=Ramesh |last7=Gorain |first7=Mahadeo |last8=Ghuwalewala |first8=Sangeeta |last9=Roychowdhury |first9=Anirban |last10=Alam |first10=Sk Kayum |last11=Das |first11=Pijush |last12=Chatterjee |first12=Raghunath |last13=Dasgupta |first13=Maitrayee |last14=Panda |first14=Chinmay Kumar |last15=Kundu |first15=Gopal C |last16=Roychoudhury |first16=Susanta |pmc=5666604}}
See also- Scientific plagiarism in India
References1. ^{{cite web | url=http://ssbprize.gov.in/Content/Detail.aspx?AID=167 | title=Brief Profile of the Awardee | publisher=Shanti Swarup Bhatnagar Prize | date=2016 | accessdate=5 October 2016}}
2. ^{{cite web | url=http://www.csirhrdg.res.in/ssb.pdf | title=Handbook of Shanti Swarup Bhatnagar Prize Winners | publisher=Council of Scientific and Industrial Research | date=1999 | accessdate=5 October 2016 | pages=34}}
3. ^{{cite web | url=http://www.ias.ac.in/describe/fellow/Kundu,_Dr_Gopal_Chandra | title=Fellow profile - G C Kundu | publisher=Indian Academy of Sciences | date=2016 | accessdate=6 October 2016}}
4. ^{{cite web|url=http://www.nasi.org.in/fellows.asp?RsFilter=K |title=NASI fellows |publisher=National Academy of Sciences, India |date=2016 |accessdate=20 October 2016 |deadurl=yes |archiveurl=https://web.archive.org/web/20160315081652/http://nasi.org.in/fellows.asp?RsFilter=K |archivedate=15 March 2016 |df= }}
5. ^{{cite web | url=http://dbtindia.nic.in/wp-content/uploads/2014/03/list_of_bioscience_awardees.pdf | title=N-BIOS Prize | publisher=Department of Biotechnology | date=2016 | accessdate=20 October 2016}}
6. ^{{cite web | url=http://ssbprize.gov.in/Content/Detail.aspx?AID=201 | title=View Bhatnagar Awardees | publisher=Shanti Swarup Bhatnagar Prize | date=2016 | accessdate=5 October 2016}}
7. ^{{cite web| title =Dr. Gopal Kundu| publisher = NCCS| date =1 January 2001| url =http://www.nccs.res.in/gck.html}}
8. ^{{cite web| title =DBT neurobiology task force| publisher = Neurobiology| date =5 March 2004| url =http://dbt-neuro.ncbs.res.in/node/74}}
9. ^{{cite web| title =Curriculum vitae| publisher = apoptosis| date =20 August 2005| url =http://www.apoptosis2005.org/profiles/gopal_kundu.htm}}
10. ^{{cite news| title =PM presents Bhatnagar prizes to 21 scientists| work = The Times of India| date =29 September 2005| author= | url =http://articles.timesofindia.indiatimes.com/2005-09-29/india/27843451_1_science-technology-shanti-swarup-bhatnagar-science-teachers}}
11. ^1 {{cite news| title =Two Pune scientists bag Bhatnagar prize| work = The Times of India| date =29 September 2004| author= | url =http://articles.timesofindia.indiatimes.com/2004-09-29/pune/27152030_1_national-chemical-laboratory-ncl-national-bioscience-award}}
12. ^{{cite web| title =Kundu-JBC Case| publisher = Society for Scientific Values| url =http://www.scientificvalues.org/kundu_case.html}}
13. ^{{cite news| title =Indicted there, acquitted here| work = The Telegraph| date =6 March 2007| author= G.S. mudur| url =http://www.telegraphindia.com/1070306/asp/frontpage/story_7476120.asp| location=Calcutta, India}}
14. ^{{cite journal| title =Investigating Misconduct in Science| author = S.P. Modak| journal = Current Science| volume=92 |issue=11 |pages=| date = 10 June 2007| url =http://www.ias.ac.in/currsci/jun102007/1469.pdf}}
15. ^{{cite journal| title =The NCCS Case| author = G. Padmanabhan| journal = Current Science| volume=92 |issue=11 |pages=| date = 10 June 2007| url =http://www.ias.ac.in/currsci/jun102007/1469.pdf}}
16. ^{{cite journal |pmid=17380579 | volume=282 | issue=8 | title=JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation | year=2007 | journal=J. Biol. Chem. | pages=5968}}
17. ^{{cite news| title = ‘Coping with misconduct in Indian science’: a response| work = The Hindu| date = 12 September 2007| author = Hema Rangaswami| url =http://www.hindu.com/2007/09/12/stories/2007091253571300.htm| location=Chennai, India}}
18. ^{{cite news| title = ‘Rehashing catches up - Once-acquitted biologist barred for 3 years’| work = The Telegraph| date = 14 November 2010| author =| url =http://www.telegraphindia.com/1101114/jsp/frontpage/story_13175152.jsp| location=Kolkata, India| first=T.V.| last=Jayan}}
{{SSBPST recipients in Biological Science}}{{N-BIOS Laureates 1999–2009}}{{authority control}}{{DEFAULTSORT:Kundu, Gopal}} 10 : Indian medical researchers|People involved in plagiarism controversies|1959 births|Living people|Scientists from Kolkata|Indian cell biologists|Fellows of the Indian Academy of Sciences|Fellows of The National Academy of Sciences, India|Recipients of the Shanti Swarup Bhatnagar Award in Biological Science|N-BIOS Prize recipients |